Although the role of NLRP3 in colitis is controversial, studies have demonstrated that NLRP3−/− mice develop less severe colitis than wild-type mice and that targeting the NLRP3 inflammasome can significantly ameliorate experimental colitis (14, 41, 42). The gene discussed is NLRP3; the disease is colitis.